36128 Federal Register / Vol. 87, No. 115 / Wednesday, June 15, 2022 / Notices 

the following types of contract 

modification requests: additional items/ 

additional SINs, deletions, and price 

reductions. At a minimum, each 

contract modification request covered 

by this clause is to include an 

explanation for the request and 

supporting information. 

B. Annual Reporting Burden 

Respondents: 14,200. 

Responses per Respondent: 1. 

Total Responses: 14,200. 

Hours per Response: 3.5. 

Total Burden Hours: 49,700. 

C. Public Comments 

A 60-day notice published in the 

Federal Register at 87 FR 19936 on 

April 6, 2022. No comments were 

received. 

Obtaining Copies of Proposals: 

Requesters may obtain a copy of the 

information collection documents from 

the GSA Regulatory Secretariat Division, 

by calling 202–501–4755 or emailing 

GSARegSec@gsa.gov. Please cite OMB 

Control No. 3090–0302, ‘‘Modifications 

(Federal Supply Schedule)’’ in all 

correspondence. 

Jeffrey A. Koses, 

Senior Procurement Executive, Office of 

Acquisition Policy, Office of Governmentwide Policy. 

[FR Doc. 2022–12887 Filed 6–14–22; 8:45 am] 

BILLING CODE 6820–61–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Agency for Healthcare Research 

and Quality, HHS. 

ACTION: Notice. 

SUMMARY: This notice announces the 

intention of the Agency for Healthcare 

Research and Quality (AHRQ) to request 

that the Office of Management and 

Budget (OMB) approve the proposed 

information collection project ‘‘Measure 

Dx: A Resource to Identify, Analyze, 

and Learn from Diagnostic Safety 

Events.’’ 

DATES: Comments on this notice must be 

received by August 15, 2022. 

ADDRESSES: Written comments should 

be submitted to: Doris Lefkowitz, 

Reports Clearance Officer, AHRQ, by 

email at doris.lefkowitz@AHRQ.hhs.gov. 

Copies of the proposed collection 

plans, data collection instruments, and 

specific details on the estimated burden 

can be obtained from the AHRQ Reports 

Clearance Officer. 

FOR FURTHER INFORMATION CONTACT: 

Doris Lefkowitz, AHRQ Reports 

Clearance Officer, (301) 427–1477, or by 

email at doris.lefkowitz@AHRQ.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Proposed Project 

Measure Dx: A Resource To Identify, 

Analyze, and Learn From Diagnostic 

Safety Events 

The Measure Dx resource (the 

Resource) is a modular toolkit that 

provides clinicians, quality and safety 

personnel, and healthcare organization 

leaders with guidance for implementing 

diagnostic safety measurement strategies 

for the purposes of learning and 

improvement. The Resource was 

developed and pilot tested (Fast Track 

OMB control number: 0935–0179) 

during the base year of an AHRQ 

contract awarded to the MedStar Health 

Research Institute and provides 

pragmatic recommendations for 

implementing measurement strategies 

that were identified in the AHRQ Issue 

Brief titled Operational Measurement of 

Diagnostic Safety: State of the Science. 

In particular, the Resource focuses on 

four broad measurement strategies that 

were assessed to be approaching 

readiness for implementation in 

operational settings. 

AHRQ is requesting full OMB 

approval to conduct a formal evaluation 

of the Resource. AHRQ would like to 

further develop this resource, expanding 

on the initial pilot test which 

qualitatively examined feasibility of 

implementing the resource, general 

receptivity, and feedback for 

improvement. 

This information collection has the 

following goal: 

1. To evaluate the Resource in order 

to stimulate measurement activities for 

learning and improvement and 

quantitatively and qualitatively 

examine: 

a. Feasibility of implementing the 

Resource with limited to no technical 

assistance; 

b. User experience and satisfaction 

with the Resource; 

c. Impact of the Resource on 

diagnostic safety policies or activities; 

d. Yield of newly detected diagnostic 

safety events and associated learning 

resulting from use of the Resource; 

e. Intent to sustain use of the Resource 

and continue with the diagnostic safety 

process following evaluation efforts. 

This information collection is being 

conducted by AHRQ through its 

contractor, MedStar Health Research 

Institute, pursuant to AHRQ’s statutory 

authority to conduct and support 

research on healthcare and on systems 

for the delivery of such care, including 

activities with respect to the quality, 

effectiveness, efficiency, 

appropriateness and value of healthcare 

services and with respect to quality 

measurement and improvement. 42 

U.S.C. 299a(a)(1) and (2). 

Method of Collection 

To achieve the goals of this project the 

following information collection 

instruments will be completed: 

(1) Organizational Characteristics 

Survey—designed to qualitatively 

describe the characteristics of the 

organizations engaged in evaluation 

(e.g., patient characteristics, practice 

size, and staffing). 

(2) Organizational Self-Assessment 

Survey—designed to qualitatively assess 

the organization’s readiness (e.g., 

leadership support, resources, and 

safety culture/infrastructure) for 

implementing the Resource. 

(3) The Safer Dx Checklist—A 

synthesis of foundational practices that 

health care organizations can use to 

advance diagnostic excellence. The 

checklist provides a framework for 

organizations to conduct a selfassessment to understand the current 

state of diagnostic practices, identify 

areas to improve, and track progress 

toward diagnostic excellence over time. 

(4) Pre-test Evaluation Interview 

Protocol—designed to qualitatively 

assess the organization’s current 

policies and structures related to 

diagnostic safety, plans for 

implementing the Resource, and initial 

feedback on resource materials. 

(5) Post-test Evaluation Interview 

Protocol—designed to qualitatively 

assess the organization’s experience 

with implementing the Resource, the 

impact of the Resource on diagnostic 

safety policies or activities in their 

organization, contextual information 

about whether and how the Resource 

facilitated case detection, and intent to 

sustain use of the Resource following 

evaluation efforts. 

(6) Team Questionnaire—adapted to 

help organizations self-assess diagnostic 

teamwork in their organization & their 

diagnostic team’s commitment to 

implementing the Resource. 

(7) Case Review Summary Form— 

designed to quantitatively and 

qualitatively summarize the diagnostic 

safety intelligence that participants have 

detected, analyzed, and/or learned from 

while implementing one Measure Dx 

strategy. 

(8) ECHO Calls Protocol—The 

purpose of virtual ECHO calls is to 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 115 / Wednesday, June 15, 2022 / Notices 36129 

foster bi-directional learning among the 

participating organizations, to check site 

progress during the implementation 

period and to understand ‘‘real-time’’ 

challenges, successes, and lessons 

learned. Standard questions for each 

ECHO session will be asked to foster 

shared learning and discussion. AHRQ 

will use the information collected to 

assess and enhance the feasibility of 

organizations in adopting the Resource 

to stimulate diagnostic safety 

measurement activities for learning and 

improvement. AHRQ’s ability to 

publicly share a diagnostic 

measurement resource that has been 

scientifically validated is expected to be 

of great interest to the health care 

community and important in helping 

organizations measure diagnostic safety 

for patient safety and quality 

improvement efforts. 

Estimated Annual Respondent Burden 

EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Hours per 

response 

Total burden 

hours 

Organizational Characteristics Survey ............................................................. 10 1 1 10 

Organizational Self-Assessment (from Measure Dx) ...................................... 10 1 .5 5 

Safer Dx Checklist ........................................................................................... 10 2 0.25 5 

Pre-Test Interview Protocol ............................................................................. 20 1 1 20 

Post-test Evaluation Interview Protocol ........................................................... 20 1 1 20 

Team Questionnaire ........................................................................................ 10 2 0.25 5 

Case Review Summary Form .......................................................................... 10 2 .75 15 

ECHO Call Protocol ......................................................................................... 10 6 1 60 

Total .......................................................................................................... 100 NA NA 140 

EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN

Form name Number of 

respondents 

Total burden 

hours 

Average 

hourly wage 

rate * 

Total cost 

burden 

Organizational Characteristics Survey ............................................................. 10 10 a $57.61 $576.1 

Organizational Self-Assessment (from Measure Dx) ...................................... 10 5 a 57.61 288.05 

Safer Dx Checklist ........................................................................................... 10 5 a 57.61 288.05 

Pre-Test Interview Protocol ............................................................................. 20 20 b 136.37 2,727.40 

Post-test Evaluation Interview Protocol ........................................................... 20 20 b 136.37 2,727.40 

Team Questionnaire ........................................................................................ 10 5 a 57.61 288.05 

Case Review Summary Form .......................................................................... 10 15 b 136.37 2,045.60 

ECHO Call Protocol ......................................................................................... 10 60 a 57.61 3,456.60 

Total .......................................................................................................... 100 140 NA 12,397.25 

* National Compensation Survey: Occupational wages in the United States May 2021 ‘‘U.S. Department of Labor, Bureau of Labor Statistics.’’ 

(https://www.bls.gov/oes/current/oes_nat.htm#29-0000). aBased on the mean wages for Medical and Health Services Managers (Code 11–9111). bBased on the mean wages for Physicians (broad) (Code 29–1210). 

Request for Comments 

In accordance with the Paperwork 

Reduction Act, 44 U.S.C. 3501–3520, 

comments on AHRQ’s information 

collection are requested with regard to 

any of the following: (a) whether the 

proposed collection of information is 

necessary for the proper performance of 

AHRQ’s health care research and health 

care information dissemination 

functions, including whether the 

information will have practical utility; 

(b) the accuracy of AHRQ’s estimate of 

burden (including hours and costs) of 

the proposed collection(s) of 

information; (c) ways to enhance the 

quality, utility and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: June 9, 2022. 

Marquita Cullom, 

Associate Director. 

[FR Doc. 2022–12828 Filed 6–14–22; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Rescinding Requirement for Negative 

Pre-Departure COVID–19 Test Result 

or Documentation of Recovery From 

COVID–19 for All Airline or Other 

Aircraft Passengers Arriving Into the 

United States From Any Foreign 

Country 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS), is hereby 

rescinding the Order titled, 


jspears on DSK121TN23PROD with NOTICES1